Table 7:
Subgroup Analyses of Glycated Hemoglobin Levels for Type 1 Diabetes Cases
| Author, Year | Mean A1C (%) | End-of-Study Mean Difference Between Flash and SMBG (95% CI) | P Valuea | |||
|---|---|---|---|---|---|---|
| Flash | SMBG | |||||
| Baseline | Study End | Baseline | Study End | |||
| Multiple daily in injections of insulin | ||||||
| Oskarsson et al, 201749 | 6.80 | 7.00 | 6.71 | 6.91 | 0.02 (−0.13 to 0.18)a,b |
.77 |
| Al Hayek et al, 201747 | NA | 7.4 | NA | 8.69 | −1.29 (−2.30 to −0.28) | .014 |
| Continuous subcutaneous insulin infusion | ||||||
| Al Hayek et al, 201747 | NA | 8.15 | NA | 8.33 | −0.18 (−1.12 to 0.76) | .7075 |
Abbreviations: A1C, glycated hemoglobin; CI, confidence interval; NA, not applicable; SMBG self-monitoring of blood glucose.
a
Confidence intervals or P values were computed by the authors of this health technology assessment using information reported in the primary studies.
b
Adjusted for baseline A1C, study centre, and mode of insulin intake.